These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6540221)

  • 1. Weekly cis-diamminedichloroplatinum II as induction chemotherapy in recurrent carcinoma of the cervix.
    Piver MS; Barlow JJ; Lele SB; Maniccia M
    Gynecol Oncol; 1984 Jul; 18(3):313-9. PubMed ID: 6540221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weekly cisplatin induction chemotherapy in the treatment of recurrent cervical carcinoma.
    Lele SB; Piver MS
    Gynecol Oncol; 1989 Apr; 33(1):6-8. PubMed ID: 2467845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combination chemotherapy with PAP (peplomycin, adriamycin and cisplatin) in recurrent uterine cervical cancer with pulmonary metastasis].
    Fujii M; Okabe K; Toki H; Araki Y; Masaoka H
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):342-3. PubMed ID: 6198971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methyl-CCNU, doxorubicin, and cis-diamminedichloroplatinum II in the management of recurrent and metastatic squamous carcinoma of the cervix.
    Carlson JA; Day TG; Allegra JC; Woodcock TM; Greenberg RA; Masterson BJ
    Cancer; 1984 Jul; 54(2):211-4. PubMed ID: 6539161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
    Thigpen T; Shingleton H; Homesley H; Lagasse L; Blessing J
    Cancer; 1981 Aug; 48(4):899-903. PubMed ID: 7196794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy for recurrent and metastatic cervical cancer with standard-dose methotrexate-leucovorin, bleomycin and cis-platinum.
    Vogl SE; Seltzer V; Camacho F; Davis TE
    J Reprod Med; 1986 May; 31(5):327-9. PubMed ID: 2427717
    [No Abstract]   [Full Text] [Related]  

  • 7. Weekly cisplatin and radical radiation therapy for advanced, recurrent, and poor prognosis cervical carcinoma.
    Malfetano J; Keys H; Kredentser D; Cunningham M; Kotlove D; Weiss L
    Cancer; 1993 Jun; 71(11):3703-6. PubMed ID: 8387884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ifosfamide, adriamycin and cisplatin (IAP) plus bleomycin (B) combination chemotherapy in patients with recurrent cancer of the uterine cervix.
    Nishida T; Nagasue N; Arimatsu T; Nagano H; Izumi S; Okura N; Matsumura T; Yakushiji M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):590-4. PubMed ID: 2474043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of cis-diamminedichloroplatinum (cis-platinum), vincristine, and peplomycin for advanced squamous cell carcinoma.
    Tamura K; Araki Y; Tateyama H; Maeda M; Seita M
    J Surg Oncol; 1987 Aug; 35(4):241-4. PubMed ID: 2441207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II trial of carboplatin and etoposide for relapsed or metastatic carcinoma of the cervix.
    Tebbutt N; Rischin D; Quinn M; Rome R; Millward MJ; Toner GC; Bishop JF
    Aust N Z J Obstet Gynaecol; 1998 Feb; 38(1):87-90. PubMed ID: 9521400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cis-diamminedichloroplatinum (II): second line induction chemotherapy in advanced ovarian adenocarcinoma.
    Piver MS; Barlow JJ; Lele SB; Malfetano JH; McPhee ME
    J Surg Oncol; 1983 Dec; 24(4):329-31. PubMed ID: 6418977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cis-platinum and mitomycin-C in treatment of recurrent, metastatic, or residual uterine cervical cancer post radiation.
    Senapad S; Neungton S; Usavajindawath C; Vijatrasil S; Thaithanaisawanya V
    J Med Assoc Thai; 1989 Jul; 72(7):382-6. PubMed ID: 2507723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of bolus cis-platinum and continuous 5-fluorouracil infusion for metastatic and recurrent squamous cell carcinoma of the cervix.
    Rotmensch J; Senekjian EK; Javaheri G; Herbst AL
    Gynecol Oncol; 1988 Jan; 29(1):76-81. PubMed ID: 3338666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix.
    Kim JS; Kim JS; Kim SY; Kim Ki; Cho MJ
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1247-53. PubMed ID: 12654434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy in recurrent and advanced cervical cancer.
    Kumar L; Bhargava VL
    Gynecol Oncol; 1991 Feb; 40(2):107-11. PubMed ID: 1707022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and Safety of Negative-Balance Isolated Pelvic Perfusion in Patients with Pretreated Recurrent or Persistent Uterine Cervical Cancer.
    Murata S; Onozawa S; Sugihara F; Sakamoto A; Ueda T; Yamaguchi H; Yasui D; Mine T; Kumita S
    Ann Surg Oncol; 2015 Nov; 22(12):3981-9. PubMed ID: 25758191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weekly versus three-weekly cisplatin as an adjunct to radiation therapy in high-risk stage I-IIA cervical cancer after surgery: a randomized comparison of treatment compliance.
    Chumworathayi B; Suprasert P; Charoenkwan K; Srisomboon J; Phongnarisorn C; Siriaree S; Cheewakriangkrai C; Tantipalakorn J; Kiatpeerakul C; Pantusart A
    J Med Assoc Thai; 2005 Nov; 88(11):1483-92. PubMed ID: 16471090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
    Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cis-platinum, doxorubicin, and methotrexate treatment for recurrent cervical cancer.
    Wheelock JB; Krebs HB; Goplerud DR; Myers M
    Obstet Gynecol; 1985 Sep; 66(3):410-2. PubMed ID: 4040622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent and/or metastatic head and neck squamous cell carcinoma: a clinical, univariate and multivariate analysis of response and survival with cisplatin-based chemotherapy.
    Recondo G; Armand JP; Tellez-Bernal E; Domenge C; Belehradek M; De Vathaire F; Wibault P; Richard JM; Cvitkovic E
    Laryngoscope; 1991 May; 101(5):494-501. PubMed ID: 1709437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.